HomeInsightsStock Comparison

Concord Drugs Ltd vs Rpg Life Sciences Ltd Stock Comparison

Concord Drugs Ltd vs Rpg Life Sciences Ltd Stock Comparison

Last Updated on: Jul 03, 2025

Key Highlights

  • The Latest Trading Price of Concord Drugs Ltd is ₹ 53.01 as of 03 Jul 12:19.
  • The P/E Ratio of Concord Drugs Ltd is 15.9 as of March 2022 .The P/E Ratio of RPG Life Sciences Ltd is 0 as of March 2022.
  • The Market Cap of Concord Drugs Ltd is ₹ 25.36 crore as of March 2022 .The Market Cap of RPG Life Sciences Ltd is ₹ 0 crore as of March 2022.
  • The revenue of Concord Drugs Ltd for the Mar '25 is ₹ 10.4 crore as compare to the Dec '24 revenue of ₹ 10.8 crore. This represent the decline of -3.7% The revenue of RPG Life Sciences Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Concord Drugs Ltd for the Mar '25 is ₹ 1.05 crore as compare to the Dec '24 ebitda of ₹ 1.39 crore. This represent the decline of -24.46% The ebitda of RPG Life Sciences Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Concord Drugs Ltd changed from ₹ 0.49 crore to ₹ 0.04 crore over 8 quarters. This represents a CAGR of -71.43% The net profit of RPG Life Sciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Concord Drugs Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of RPG Life Sciences Ltd changed from 24.66 % on March 2020 to 18.05 % on March 2025 . This represents a CAGR of -5.07% over 6 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Concord Drugs Ltd

  • Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved.
  • The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad.
  • State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.

About RPG Life Sciences Ltd

  • RPG Life Sciences Limited, formerly known as Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group.
  • The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited'.
  • During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007.
  • On February 13, 2008, the name of the Company was changed to RPG Life Sciences Limited. During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes.

Concord Drugs Ltd News Hub

News

Concord Drugs to hold board meeting

Concord Drugs will hold a meeting of the Board of Directors of the Company on 3 July 2025....

Read more

01 Jul 2025 14:20

News

Concord Drugs to hold board meeting

Concord Drugs will hold a meeting of the Board of Directors of the Company on 27 June 2025...

Read more

20 Jun 2025 10:07

News

Concord Drugs to announce Quarterly Result

Concord Drugs will hold a meeting of the Board of Directors of the Company on 23 May 2025....

Read more

17 May 2025 15:21

News

Concord Drugs postpones board meeting

Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to b...

Read more

14 Mar 2025 10:07

News

Concord Drugs to convene board meeting

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 March 202...

Read more

05 Mar 2025 09:36

News

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 11 January 2...

Read more

08 Jan 2025 10:15

RPG Life Sciences Ltd News Hub

News

RPG Life Sciences schedules AGM

RPG Life Sciences announced that the 18th Annual General Meeting(AGM) of the company will ...

Read more

16 Jun 2025 15:14

News

Board of RPG Life Sciences recommends special dividend

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held...

Read more

29 Apr 2025 09:35

News

Board of RPG Life Sciences recommends final dividend

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held...

Read more

29 Apr 2025 09:35

News

RPG Life edges higher after Q4 PAT rises 64% YoY to nearly Rs 22 crore

Net sales rose by 12.7% year-over-year (YoY) to Rs 143.09 crore during the period under re...

Read more

29 Apr 2025 11:35

News

RPG Life Sciences to hold board meeting

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 28 April...

Read more

22 Apr 2025 09:39

News

RPG Life Sciences soars as PAT jump 32% YoY to Rs 35 crore in Q3 FY25

Profit before tax (PBT) gained 31.93% to Rs 46.89 crore in Q3 FY25 from Rs 35.54 crore in ...

Read more

27 Jan 2025 11:51

SWOT Analysis Of RPG Life Sciences Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for RPG Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Concord Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Concord Drugs Ltd and RPG Life Sciences Ltd

Which company has a larger market capitalization, Concord Drugs Ltd or RPG Life Sciences Ltd?

Market cap of Concord Drugs Ltd is 51 Cr while Market cap of RPG Life Sciences Ltd is 4,139 Cr

What are the key factors driving the stock performance of Concord Drugs Ltd and RPG Life Sciences Ltd?

The stock performance of Concord Drugs Ltd and RPG Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Concord Drugs Ltd and RPG Life Sciences Ltd?

As of July 3, 2025, the Concord Drugs Ltd stock price is INR ₹51.45. On the other hand, RPG Life Sciences Ltd stock price is INR ₹2503.05.

How do dividend payouts of Concord Drugs Ltd and RPG Life Sciences Ltd compare?

To compare the dividend payouts of Concord Drugs Ltd and RPG Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions